Bedside ultrasound, including echocardiography, lung ultrasound, and VexUS, provides a reliable noninvasive method to assess cardiac function and guide interventions in the CICU.
Bedside ultrasound, including echocardiography, lung ultrasound, and VexUS, serves as a fundamental noninvasive tool for personalized hemodynamic monitoring and guiding therapy in the cardiac intensive care unit.
Thanks to the advances in medical therapy and assist devices, the management of patients hospitalized in cardiac intensive care unit (CICU) is becoming increasingly challenging. In fact, Patients in the cardiac intensive care unit are frequently characterized by dynamic and variable diseases, which may evolve into several clinical phenotypes based on underlying etiology and its complexity. Therefore, the use of noninvasive tools in order to provide a personalized approach to these patients, according to their phenotype, may help to optimize the therapeutic strategies towards the underlying etiology. Echocardiography is the most reliable and feasible bedside method to assess cardiac function repeatedly, assisting clinicians not only in characterizing hemodynamic disorders, but also in helping to guide interventions and monitor response to therapies. Beyond basic echocardiographic parameters, its application has been expanded with the introduction of new tools such as lung ultrasound (LUS), the Venous Excess UltraSound (VexUS) grading system, and the assessment of pulmonary hypertension, which is fundamental to guide oxygen therapy. The aim of this review is to provide an overview on the current knowledge about the pathophysiology and echocardiographic evaluation of perfusion and congestion in patients in CICU, and to provide practical indications for the use of echocardiography across clinical phenotypes and new applications in CICU.
Pastore et al. (Mon,) conducted a review in Patients in cardiac intensive care unit (CICU). Bedside ultrasound (echocardiography, LUS, VexUS) was evaluated. Bedside ultrasound, including echocardiography, lung ultrasound, and VexUS, provides a reliable noninvasive method to assess cardiac function and guide interventions in the CICU.